These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 8637903)

  • 1. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
    Gerritse K; Laman JD; Noelle RJ; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2499-504. PubMed ID: 8637903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide.
    Laman JD; Maassen CB; Schellekens MM; Visser L; Kap M; de Jong E; van Puijenbroek M; van Stipdonk MJ; van Meurs M; Schwärzler C; Günthert U
    Mult Scler; 1998 Jun; 4(3):147-53. PubMed ID: 9762665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE).
    Constantinescu CS; Hilliard B; Wysocka M; Ventura ES; Bhopale MK; Trinchieri G; Rostami AM
    J Neurol Sci; 1999 Dec; 171(1):60-4. PubMed ID: 10567051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
    Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
    J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells.
    Wykes M; Poudrier J; Lindstedt R; Gray D
    Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.
    Howard LM; Miga AJ; Vanderlugt CL; Dal Canto MC; Laman JD; Noelle RJ; Miller SD
    J Clin Invest; 1999 Jan; 103(2):281-90. PubMed ID: 9916140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 in clinical inflammation: from multiple sclerosis to atherosclerosis.
    Laman JD; De Boer M; Hart BA
    Dev Immunol; 1998; 6(3-4):215-22. PubMed ID: 9814595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation.
    Samoilova EB; Horton JL; Zhang H; Chen Y
    J Mol Med (Berl); 1997 Aug; 75(8):603-8. PubMed ID: 9297628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
    Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
    Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions.
    Liu Z; Geboes K; Colpaert S; Overbergh L; Mathieu C; Heremans H; de Boer M; Boon L; D'Haens G; Rutgeerts P; Ceuppens JL
    J Immunol; 2000 Jun; 164(11):6005-14. PubMed ID: 10820284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L.
    Kim DY; Hong GU; Ro JY
    J Neuroinflammation; 2011 Mar; 8():25. PubMed ID: 21410936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
    Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions of CD40 and Its Ligand, gp39 (CD40L).
    Laman JD; Claassen E; Noelle RJ
    Crit Rev Immunol; 2017; 37(2-6):371-420. PubMed ID: 29773027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses.
    Boon L; Brok HP; Bauer J; Ortiz-Buijsse A; Schellekens MM; Ramdien-Murli S; Blezer E; van Meurs M; Ceuppens J; de Boer M; 't Hart BA; Laman JD
    J Immunol; 2001 Sep; 167(5):2942-9. PubMed ID: 11509643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.
    Mach F; Schönbeck U; Sukhova GK; Bourcier T; Bonnefoy JY; Pober JS; Libby P
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1931-6. PubMed ID: 9050882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
    Schoenberger SP; Toes RE; van der Voort EI; Offringa R; Melief CJ
    Nature; 1998 Jun; 393(6684):480-3. PubMed ID: 9624005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction.
    Carayanniotis G; Masters SR; Noelle RJ
    Immunology; 1997 Mar; 90(3):421-6. PubMed ID: 9155650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction.
    Imaizumi K; Kawabe T; Ichiyama S; Kikutani H; Yagita H; Shimokata K; Hasegawa Y
    Am J Physiol; 1999 Jul; 277(1):L49-57. PubMed ID: 10409230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.